Can an organic compound tame COVID-19 in High-Risk patients?
Disease control
Terminated
This trial is testing an organic compound called NP-101 in adults with mild-to-moderate COVID-19 who are at high risk of severe illness. The study aims to find the safest and most effective dose, and to see whether NP-101 can help patients recover faster and reduce the amount of …
Phase: PHASE2 • Sponsor: Novatek Pharmaceuticals • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC